The PTH (1-84)/non-PTH (1-84) ratio is a risk factor for cardiovascular events in hemodialysis patients

被引:8
作者
Zitt, E. [2 ,3 ]
Kirsch, A. H.
Haueis, M.
Strasak, A. [4 ]
Neyer, U. [2 ,3 ]
Mayer, G.
Rosenkranz, A. R. [1 ]
机构
[1] Med Univ Innsbruck, Univ Klin Innere Med 4, Dept Internal Med 4, A-6020 Innsbruck, Austria
[2] Acad Teaching Hosp Feldkirch, Dept Nephrol & Dialysis, Feldkirch, Austria
[3] VIVIT, Feldkirch, Austria
[4] Med Univ Innsbruck, Dept Med Stat, A-6020 Innsbruck, Austria
关键词
PTH; secondary hyperparathyroidism; PTH (1-84)/non-PTH (1-84) ratio; cardiovascular morbidity; cardiovascular mortality; hemodialysis; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; PARATHYROID-HORMONE ASSAYS; INCIDENT DIALYSIS PATIENTS; ALL-CAUSE MORTALITY; VASCULAR CALCIFICATION; BONE HISTOMORPHOMETRY; MINERAL METABOLISM; SERUM-CALCIUM; ASSOCIATION;
D O I
10.5414/CNP75309
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: We hypothesized that the PTH (1-84)/non-PTH (1-84) ratio (PTH ratio) might help to assess cardiovascular risk in hemodialysis patients. Methods: In this prospective cohort study 70 prevalent hemodialysis patients were followed up to 4 years. The PTH ratio was determined at base-line. Primary outcomes were cardiovascular events (CV E) and all-cause mortality. Cumulative event-free survival was compared between patients with a ratio < 1 and those with a ratio > 1. The risk-association of the PTH ratio with CVE was examined using an adjusted Multiple Cox Proportional Hazards model. Results: A PTH ratio > 1 was found in 34 patients (49%). During follow-up 26 patients suffered a CVE. Patients with a CVE showed a higher ratio than patients with event-free survival (p = 0.033). In patients with a ratio > 1 a significantly higher number of CVE occurred (53 vs. 22%; p = 0.013), and these patients showed a significantly shorter event-free survival (p = 0.032). In an adjusted Cox-proportional hazards model a higher PTH ratio was found to be independently associated with an elevated risk for CVE (HR = 3.2; 95% Cl 1.06 - 13.63; p = 0.04). Conclusions: A higher PTH (1-84)/non-PTH (1-84) ratio is associated with an increased risk for CVE in hemodialysis patients and might therefore be useful for cardiovascular risk estimation in this population.
引用
收藏
页码:309 / 318
页数:10
相关论文
共 50 条
  • [1] The reversed ratio of 1-84 PTH (whole PTH)/intact PTH in a patient on hemodialysis associated with primary hyperparathyroidism
    Mizumura, Y.
    Mukaiyama, Y.
    Osada, H.
    Hida, O.
    Nishimiya, M.
    Nakamura, Y.
    CLINICAL NEPHROLOGY, 2008, 69 (04) : 310 - 312
  • [2] Clinical evaluation of two novel biointact PTH(1-84) assays in hemodialysis patients
    Hecking, Manfred
    Kainz, Alexander
    Bielesz, Bernhard
    Plischke, Max
    Beilhack, Georg
    Hoerl, Walter H.
    Sunder-Plassmann, Gere
    Bieglmayer, Christian
    CLINICAL BIOCHEMISTRY, 2012, 45 (18) : 1645 - 1651
  • [3] Significance of Bio-intact PTH(1-84) assay in hemodialysis patients
    Inaba, M
    Okuno, S
    Imanishi, Y
    Ueda, M
    Yamakawa, T
    Ishimura, E
    Nishizawa, Y
    OSTEOPOROSIS INTERNATIONAL, 2005, 16 (05) : 517 - 525
  • [4] Increased active PTH(1-84) fraction as a predictor of poor mortality in male hemodialysis patients
    Inaba, M.
    Okuno, S.
    Imanishi, Y.
    Ishimura, E.
    Yamakawa, T.
    Shoji, S.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (11) : 2863 - 2870
  • [5] Influence of nutritional status on serum large N-truncated PTH, but not PTH(1-84) in hemodialysis patients
    Shidara, Kaori
    Inaba, Masaaki
    Okuno, Senji
    Imanishi, Yasuo
    Yamakawa, Tomoyuki
    Ishimura, Eiji
    Kumeda, Yasuro
    Nishizawa, Yoshiki
    BIOMEDICINE & PHARMACOTHERAPY, 2007, 61 (2-3) : 142 - 147
  • [6] PTH Substitution Therapy for Chronic Hypoparathyroidism: PTH 1-84 and Palopegteriparatide
    Palermo, Andrea
    Naciu, Anda Mihaela
    Donovan, Yu Kwang Tay
    Tabacco, Gaia
    Zavatta, Guido
    CURRENT OSTEOPOROSIS REPORTS, 2025, 23 (01)
  • [7] Whole PTH and 1-84/7-84 PTH ratio for the non invasive determination of low bone turnover in renal osteodystrophy
    Negri, AL
    Quiroga, MA
    Bravo, M
    Fradinger, E
    de Marino, AJ
    Bogado, CE
    Zanchetta, JR
    NEFROLOGIA, 2003, 23 (04): : 327 - 332
  • [8] Increased circulating concentrations of bioactive PTH 1-84 in patients with heart failure
    Gruson, D.
    Lepoutre, T.
    Ahn, S. A.
    Ketelslegers, J. M.
    Rousseau, M. F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (11) : 987 - 991
  • [9] Positive correlation of serum bio-intact PTH(1-84) but not intact PTH with parathyroid gland size in hemodialysis patients
    Inaba, M
    Okuno, S
    Chou, H
    Imanishi, Y
    Ueda, M
    Yamakawa, T
    Ishimura, E
    Nishizawa, Y
    BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (02) : 62 - 65
  • [10] Atrophic femoral bone nonunion treated with 1-84 PTH
    Paridis, D.
    Karachalios, Th.
    JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2011, 11 (04) : 320 - 323